More recently, we also reported that upregulation of the bromodomain-containing protein BRD4 contributes to aberrant superenhancer formation in HCC, and genetic ablation or pharmacological inactivation of BRD4 markedly abolished superenhancer-mediated oncogene expression and thereby suppressing HCC growth40. This evidence concerns the gene BRD4 and hepatocellular carcinoma.